Bio-Carbamazepine 200 200 mg Tablets.
PDF Leaflet Revision Date: 7 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Epilepsy and trigeminal neuralgia.
Dosage (summary)
Adults: 200 mg twice daily, increase as needed. Max 1600 mg/day. Children: 10-20 mg/kg/day, max 1000 mg.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to risks of malformations and adverse effects.
Key Drug Interactions
- CYP3A4 inducers/inhibitors
- MAO inhibitors
- Hormonal contraceptives
Contraindications
- Hypersensitivity to carbamazepine
- History of bone marrow depression
- Atrioventricular block
- Porphyria
Common side effects
- Dizziness
- Drowsiness
- Nausea
- Allergic skin reactions
Counselling Points
- Monitor for skin reactions
- Avoid alcohol
- Use effective contraception
Serious warnings
- Risk of SJS/TEN
- Agranulocytosis
- Suicidal ideation
Important Disclaimer
The Bio-Carbamazepine 200 200 mg Tablets. professional information leaflet below is the property of Biotech Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
